Presented By:
Jennifer Chiji-Aguma, MD, Carle Family Medicine
Kristina Dakis, MD, FAAFP, Family Health Care of Gibson City

Learning Objectives:
Describe the burden of RSV disease in infants and the role of maternal and infant immunization strategies in reducing severe outcomes. 
Explain the most recent clinical recommendations for maternal RSV vaccination (*Abrysvo*) and monoclonal antibodies (Nirsevimab - Beyfortus) use in infants. 
Differentiate between maternal immunization and infant monoclonal antibody protection, including their mechanisms of action, timing, and target populations. 
Implement best practices for vaccine administration and management, including proper storage, handling, documentation, and billing for RSV prevention strategies. 
Develop effective patient communication strategies to address vaccine hesitancy and improve uptake among pregnant individuals and parents of newborns. 
Integrate RSV vaccination and monoclonal antibody recommendations into routine clinical workflows for family physicians, obstetricians, and pediatricians to ensure comprehensive infant protection. 

Support: 
This educational activity is supported by an independent medical education grant from Pfizer.

Accreditation:
The Illinois Academy of Family Physicians (IAFP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 

Webinar Credit Designation:
AMA PRA Category 1 - The Illinois Academy of Family Physicians designates this internet live activity for a maximum of 7 AMA PRA Category 1 credits™.

AAFP Prescribed Credit - Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.